Visual Stimulation for Stroke Recovery

N/A

Recruiting

Led By Joan Stilling, MD,MS

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥ 18 years old

Be older than 18 years old

Must not have

Unable to communicate effectively or provide informed consent

Spasticity or increased tone with MAS ≥3 in the upper extremity

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, post- treatment, 3 months post-treatment.baseline (week 1, visit 1), post- treatment (weeks 6-9, visit 14), 3 months post-treatment (weeks 18-21, visit 15)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to see if using the IVS3 device can help improve satisfaction and arm function in patients with chronic stroke. Researchers believe that using the IVS3 device will be manageable and well-t

Who is the study for?

This trial is for English-speaking adults over 18 who had a stroke at least 6 months ago, with moderate upper limb impairments. It's not for those with severe muscle stiffness in the arm, significant vision problems, current pregnancy or incarceration, or if they're getting similar therapy outside the study.

What is being tested?

The trial is testing a device called IVS3 on outpatients who have had a stroke. The goal is to see if using this device helps improve satisfaction and function of the upper limbs (like arms and hands) after chronic stroke.

What are the potential side effects?

Since it's not mentioned specifically in the provided information, side effects are likely minimal but may include discomfort from using the device or fatigue during intensive visual stimulation sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I can communicate effectively and provide informed consent.

Select...

My arm is very stiff or has spasms, with a score of 3 or more.

Select...

I have major issues with my vision.

Select...

I am currently receiving occupational therapy not related to this study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, post- treatment, 3 months post-treatment.baseline (week 1, visit 1), post- treatment (weeks 6-9, visit 14), 3 months post-treatment (weeks 18-21, visit 15)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, post- treatment, 3 months post-treatment.baseline (week 1, visit 1), post- treatment (weeks 6-9, visit 14), 3 months post-treatment (weeks 18-21, visit 15)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post- treatment, 3 months post-treatment.baseline (week 1, visit 1), post- treatment (weeks 6-9, visit 14), 3 months post-treatment (weeks 18-21, visit 15) for reporting.